Key result
Salvianolic acid A inhibited EV71 3C protease activity with an IC50 of 0.69 µM and effectively suppressed EV71 infection in multiple cell lines.
Why the study?
EV71 is a major pathogen causing hand, foot, and mouth disease with risk of exacerbation and death, but no clinically available anti-EV71 specific drugs exist.
Effect estimate: IC50 0.69 µM
Salvianolic acid A demonstrates preclinical efficacy as a novel EV71 3C protease inhibitor, suggesting potential as an antiviral candidate.
No immediate clinical role; leaves open further preclinical validation of TCM-derived EV71 inhibitors.
Hand, foot, and mouth disease (HFMD) is a common childhood infectious disease caused by enterovirus (EV) infection. EV71 is one of the major pathogens causing hand, foot, and mouth disease and is more likely to cause exacerbation and death than other enteroviruses. Although a monovalent vaccine for EV71 has been developed, there are no clinically available anti-EV71 specific drugs. Here, we performed virtual screening and biological experiments based on the traditional Chinese medicine monomer library. We identified a traditional Chinese medicine monomer, Salvianolic acid A (SA), a polyphenolic compound isolated from Salvia miltiorrhiza . Salvianolic acid A inhibits EV71 virus infection in a concentration-dependent manner, and its antiviral activity is higher than that of other reported natural polyphenols and has a high biosafety. Furthermore, molecular dynamics simulations showed that salvianolic acid A can anchor to E71, a member of the enzyme catalytic triad, and cause H40 to move away from the catalytic center. Meanwhile, molecular mechanics generalized born surface area (MMGBSA) and steered molecular dynamics (SMD) results showed that the P1 group of SA was most easily unbound to the S1 pocket of 3C pro , which provided theoretical support to further improve the affinity of salvianolic acid A with 3C pro . These findings suggest that salvianolic acid A is a novel EV71 3C pro inhibitor with excellent antiviral activity and is a promising candidate for clinical studies.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2023) studied Enterovirus 71 infection. Salvianolic acid A vs. Control was evaluated on Inhibition of 3C protease hydrolytic activity (IC50) (IC50 0.69 µM). Salvianolic acid A inhibited EV71 3C protease activity with an IC50 of 0.69 µM and effectively suppressed EV71 infection in multiple cell lines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: